Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocel...
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
About this item
Full title
Author / Creator
Hiraoka, Atsushi , Kumada, Takashi , Atsukawa, Masanori , Hirooka, Masashi , Tsuji, Kunihiko , Ishikawa, Toru , Takaguchi, Koichi , Kariyama, Kazuya , Itobayashi, Ei , Tajiri, Kazuto , Shimada, Noritomo , Shibata, Hiroshi , Ochi, Hironori , Tada, Toshifumi , Toyoda, Hidenori , Nouso, Kazuhiro , Tsutsui, Akemi , Nagano, Takuya , Itokawa, Norio , Hayama, Korenobu , Imai, Michitaka , Joko, Kouji , Tanaka, Hironori , Tamai, Tsutomu , Koizumi, Yohei , Hiasa, Yoichi , Michitaka, Kojiro , Kudo, Masatoshi , Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background/Aim: We evaluated clinical factors related to improved prognosis of unresectable hepatocellular carcinoma patients (u-HCC), who were treated with tyrosine kinase inhibitor (TKI) sequential therapy, including lenvatinib (LEN). Materials/Methods: We enrolled 84 u-HCC cases treated with TKIs including LEN from March 2018 to January 2019 (me...
Alternative Titles
Full title
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
Authors, Artists and Contributors
Author / Creator
Kumada, Takashi
Atsukawa, Masanori
Hirooka, Masashi
Tsuji, Kunihiko
Ishikawa, Toru
Takaguchi, Koichi
Kariyama, Kazuya
Itobayashi, Ei
Tajiri, Kazuto
Shimada, Noritomo
Shibata, Hiroshi
Ochi, Hironori
Tada, Toshifumi
Toyoda, Hidenori
Nouso, Kazuhiro
Tsutsui, Akemi
Nagano, Takuya
Itokawa, Norio
Hayama, Korenobu
Imai, Michitaka
Joko, Kouji
Tanaka, Hironori
Tamai, Tsutomu
Koizumi, Yohei
Hiasa, Yoichi
Michitaka, Kojiro
Kudo, Masatoshi
Real-life Practice Experts for HCC (RELPEC) Study Group
HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_31307035
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31307035
Other Identifiers
ISSN
0030-2414
E-ISSN
1423-0232
DOI
10.1159/000501281
